Evidence map›Paper›PMID 31438887›Full record

ArticleBMC cancer2019

SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.

Horacio Gomez-Acevedo, John D Patterson, Sehrish Sardar, Murat Gokden, Bhaskar C Das, David W Ussery, Analiz Rodriguez

Abstract readCase Reports
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Horacio Gomez-AcevedoDepartment of Biomedical Informatics, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA.
John D PattersonDepartment of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Sehrish SardarDepartment of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Murat GokdenDivision of Neuropathology, Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Bhaskar C DasDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
David W UsseryDepartment of Biomedical Informatics, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA.
Analiz RodriguezDepartment of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. arodriguez@uams.edu.ORCID http://orcid.org/0000-0003-3426-0508

Funding

Understanding the Negative Prognostic Impact of Intraosseous Focal Lesions in Multiple MyelomaP20GM125503 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Sanja Novak · 2018 to 2026
$23.0M
NIGMS NIH HHS P20 GM125503NIH HHS P20GM125503
6 · The paper itself

Abstract

backgroundSMARCB1-deficient sinonasal carcinoma (SDSC) is an aggressive subtype of head and neck cancers that has a poor prognosis despite multimodal therapy. We present a unique case with next generation sequencing data of a patient who had SDSC with perineural invasion to the trigeminal nerve that progressed to a brain metastasis and eventually leptomeningeal spread. CASE PRESENTATION: A 42 year old female presented with facial pain and had resection of a tumor along the V2 division of the trigeminal nerve on the right. She underwent adjuvant stereotactic radiation. She developed further neurological symptoms and imaging demonstrated the tumor had infiltrated into the cavernous sinus as well as intradurally. She had surgical resection for removal of her brain metastasis and decompression of the cavernous sinus. Following her second surgery, she had adjuvant radiation and chemotherapy. Several months later she had quadriparesis and imaging was consistent with leptomeningeal spread. She underwent palliative radiation and ultimately transitioned quickly to comfort care and expired. Overall survival from time of diagnosis was 13 months. Next generation sequencing was carried out on her primary tumor and brain metastasis. The brain metastatic tissue had an increased tumor mutational burden in comparison to the primary.

conclusionsThis is the first report of SDSC with perineural invasion progressing to leptomeningeal carcinomatosis. Continued next generation sequencing of the primary and metastatic tissue by clinicians is encouraged toprovide further insights into metastatic progression of rare solid tumors.

Indexed as

AdultBiomarkers, TumorCarcinomaDisease ProgressionFemaleHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryMeningeal CarcinomatosisNeoplasm MetastasisNeoplasm StagingParanasal Sinus NeoplasmsPolymorphism, Single NucleotideSMARCB1 ProteinTomography, X-Ray ComputedBiomarkers, TumorSMARCB1 ProteinSMARCB1 protein, humanHead and neck carcinomaLeptomeningeal carcinomatosisNext generation sequencingPerineural invasionSMARCB1 deficient sinonasal carcinoma

Identifiers

PMID31438887
PMCPMC6704572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.